Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Raisio - Nutraceutical Pioneer - Top Performing Stock

No earlier versions found for this Subject.

Return to Raisio - Nutraceutical Pioneer - Top Performing Stock

Raisio was the #1 performing stock in Europe in 1996 and 1997 based on its groundbreaking nutraceutical (merger of nutrition & pharmaceuticals) product, Benecol. (Helsinki exchange:RAIS)

Raisio has a worldwide license agreement with the McNeill Consumer Products, a division of Johnson & Johnson, to market Benecol.

Raisio stock is expected to recieve a major boost in January,1999 when its Benecol margarine product is introduced to the US market with an $80 million advertising campaign.

There are numerous analyst reports published on Raisio, most notably by CS First Boston,SBC Warburg,Paribas and Merrill Lynch.

Critical competitors include Unilever and Forbes Medi-Tech/Novartis. Forbes Medi-Tech is a pure play in this area and trades at only 3% of Raisio's market capitalization. See SI Stocktalk under FMI.